Vladislav S. Bobrov

Vladislav S. Bobrov

Auto-generated profile, based on publicly available information

Vladislav S. Bobrov


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2026 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
DYDenis Eduardovich Yakobson
Denis Eduardovich Yakobson
VKVasilisa I. Kulikova
Vasilisa I. Kulikova
VBVladislav S. Bobrov
Vladislav S. Bobrov
AGAnna A. Gadeeva
Anna A. Gadeeva
MZMikhail N. Zharkov
Mikhail N. Zharkov
NPNikolay Pyataev
Nikolay Pyataev
Introduction: The prospects for using magnetic hyperthermia in cancer therapy are largely determined by the properties of the magnetic nanoparticles (MNPs), including heating efficiency, biosafety, and bioresorption capacity. In this study, we performed a comparative in vivo assessment of the toxicity and bioresorption of Fe3O4- and Zn0.2Mn0.8Fe2O4-based MNPs stabilized with oleic acid/sodium oleate (OA) or amino-functionalized silicon dioxide (SiO2–NH2). Materials and Methods: Four types of MNPs were synthesized: Fe3O4@OA, Zn0.2Mn0.8Fe2O4@OA, Fe3O4@SiO2–NH2 and Zn0.2Mn0.8Fe2O4@SiO2–NH2. The particles were characterized using DLS, TEM and vibrating sample magnetometry. Acute toxicity was evaluated in BALB/c mice after a single intraperitoneal or intramuscular administration. Biosafety and bioresorption after intramuscular administration were assessed on days 2, 14, and 90, using hematological and biochemical blood tests, histological examination, sample magnetization, and total iron content in tissues. Results and Discussion: After intraperitoneal administration, the LD50 values were 904 mg/kg for Fe3O4@OA, 1145 mg/kg for Zn0.2Mn0.8Fe2O4@OA, and 2955 mg/kg for Zn0.2Mn0.8Fe2O4@SiO2–NH2, whereas the LD50 for Fe3O4@SiO2–NH2 was not reached. After intramuscular administration at a dose of 1020 mg/kg, neither deaths nor pronounced systemic toxicity was observed. By day 90, MNPs with an oleic acid/sodium oleate-based coating showed a decrease in magnetic signal and total iron content at the injection site, whereas SiO2–NH2-coated nanoparticles remained in muscle tissue. Conclusion: The study showed that the chemical nature of the coating is one of the main factors determining the toxicity and bioresorption of Fe3O4 and Zn0.2Mn0.8Fe2O4 MNPs. Particles with a SiO2–NH2 coating were characterized by lower acute toxicity after intraperitoneal administration compared with MNPs coated with oleic acid/sodium oleate. After intramuscular administration at a dose of 1020 mg/kg, neither mortality nor pronounced signs of systemic toxicity were detected for any type of MNPs. It was also shown that the coating type affects the possibility and rate of bioresorption: after intramuscular administration at a dose of 256 mg/kg, MNPs with a SiO2–NH2 coating remained at the injection site for 90 days, whereas the oleic acid/sodium oleate-based coating promoted bioresorption.

17 August 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DYDenis Eduardovich Yakobson
Denis Eduardovich Yakobson
MZMikhail N. Zharkov
Mikhail N. Zharkov
OKOleg Alexandrovich Kulikov
Oleg Alexandrovich Kulikov
VKVasilisa I. Kulikova
Vasilisa I. Kulikova
VBVladislav S. Bobrov
Vladislav S. Bobrov
NPNikolay Pyataev
Nikolay Pyataev
Background/Objectives: Combining chemotherapy with local magnetic hyperthermia (MHT) is promising because heating tumor tissue can increase cell damage, sensitize cells to cytostatic drugs, impair DNA repair, and change tumor microenvironment permeability. This creates conditions for enhancing the antitumor efficacy of chemotherapy while potentially reducing systemic toxicity. The aim of this study was to evaluate the efficacy of MHT with Zn0.2Mn0.8Fe2O4@OA nanoparticles alone and in combination with cisplatin in a Lewis lung carcinoma model. Methods: Four types of magnetic nanoparticles were synthesized and characterized: Fe3O4 and Zn0.2Mn0.8Fe2O4 coated with oleic acid (OA) or SiO2-NH2. Their physicochemical and magnetothermal properties, cytotoxicity, reactive oxygen species generation, and biodegradation in vivo were evaluated. Antitumor efficacy was studied in C57Bl/6 mice with LLC tumors after intratumoral administration of nanoparticles and two MHT sessions (100 kHz, 8 kA/m, 30 min). In combination therapy, ZnMn@OA and cisplatin at doses of 9 or 18 mg/kg were used. Results/Conclusions: Zn0.2Mn0.8Fe2O4@OA combined efficient heating, biodegradation, and the most pronounced effect among the MHT-alone groups, although MHT without chemotherapy did not provide sustained inhibition of tumor growth or a significant increase in survival. The combination of Zn0.2Mn0.8Fe2O4@OA-MHT with cisplatin 9 mg/kg produced the best therapeutic outcome: median survival increased significantly by two fold compared with the control group and by 1.8-fold compared with the chemotherapy-alone group at the comparable cisplatin dose. This regimen also stabilized body weight, reduced systemic toxicity, and restored RBC, HGB, and HCT parameters to the level of healthy animals by day 7 of the experiment. These data confirm the potential of MHT as a chemosensitizing approach that improves the efficacy and tolerability of cisplatin therapy.

16 September 2026 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
PRPolina Ryabochkina
Polina Ryabochkina
AAAleksandra S. Alekseeva
Aleksandra S. Alekseeva
ABArtem S. Bikeev
Artem S. Bikeev
VKVasilisa I. Kulikova
Vasilisa I. Kulikova
OKOleg Alexandrovich Kulikov
Oleg Alexandrovich Kulikov
TVTatiana V. Volkova
Tatiana V. Volkova